A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer

2021 ◽  
Author(s):  
Patricia LoRusso ◽  
Erika Hamilton ◽  
Cynthia Ma ◽  
Neelima Vidula ◽  
Rebecca G. Bagley ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Androgen Receptor ◽  
Phase 1 ◽  
Metastatic Breast ◽  
Selective Androgen Receptor Modulator ◽  
Phase 1 Study ◽  
Receptor Modulator

Phase 1 study of triweekly nab-paclitaxel combined with S-1 in patients with HER2 negative metastatic breast cancer.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e12510-e12510
Author(s):  
Katsuhiko Nakatsukasa ◽  
Tetsuya Taguchi ◽  
Kouichi Sakaguchi ◽  
Yoshihumi Hujita
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase 1 ◽  
Metastatic Breast ◽  
Phase 1 Study

Study TTC-352-101: Phase 1 study of TTC-352 in patients with metastatic breast cancer (BC) progressing on endocrine therapy.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS1108-TPS1108 ◽  
Author(s):  
Ruth O'Regan ◽  
Randolph Hurley ◽  
Jasgit C. Sachdev ◽  
Debra A. Tonetti ◽  
Gregory R. Thatcher ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Endocrine Therapy ◽  
Phase 1 ◽  
Metastatic Breast ◽  
Phase 1 Study

scholarly journals A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

Cancer ◽  
2011 ◽  
Vol 118 (9) ◽  
pp. 2378-2384 ◽  
Author(s):  
Stacy Moulder ◽  
Gregory Gladish ◽  
Joe Ensor ◽  
Ana Maria Gonzalez-Angulo ◽  
Massimo Cristofanilli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase 1 ◽  
Metastatic Breast ◽  
Phase 1 Study
Sign in / Sign up

Export Citation Format

Share Document